๐ Molbio Diagnostics IPO hits 21% premium on listing
Molbio Diagnostics shares debuted strongly, listing at a 21 per cent premium over its initial public offering price. The company, based in New Delhi, saw its shares open at โน980 on both BSE and NSE on August 17, 2026. The โน940 crore IPO, which had a price band of โน768 to โน807, garnered an incredible 70.26 times bids. This strong performance is attributed to its leadership in molecular diagnostics and growth strategy. Investors are advised to remain disciplined after this sharp initial gain, according to analysts. ๐